This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Vestibular Migraine
+1

Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness

Sponsored by Mayo Clinic

About this trial

Last updated 10 years ago

Study ID

12-002814

Status

Completed

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 11 years ago

What is this trial about?

Vestibular migraine (VM) and chronic subjective dizziness (CSD) commonly cause vertigo, unsteadiness and dizziness. Clinical investigators are studying these illnesses to understand them better. VM and CSD occur together in about 1/3 of patients. That makes it hard to diagnose them accurately and decide what treatments to use. As a result, doctors and patients may be confused about these diagnoses. The goal of this study was use two different medications to tease apart the symptoms of VM and CSD. Patients who have VM and CSD together were given either verapamil or sertraline for 12 weeks. These medications are used to treat VM and CSD, though they are not approved for this purpose. Verapamil is believed to have stronger effects on symptoms of VM. Sertraline is believed to have stronger effects on symptoms of CSD. By comparing the responses of patients to these two medications, the researchers hoped to learn more about the key features of VM and CSD.

What are the participation requirements?

Yes

Inclusion Criteria

1. Neurotologic diagnoses of both vestibular migraine and chronic subjective dizziness

2. All other co-existing medical or psychiatric conditions are stable, and no greater than moderate severity

3. Able to complete study assessments in person and by phone

4. Able to travel to Mayo Clinic, Rochester, Minnesota for first and last study visits

5. Willing to avoid pregnancy during study (abstinence or acceptable birth control)

No

Exclusion Criteria

1. Presence of any other active neurotologic diagnoses

2. Medical or psychiatric conditions that would preclude or confound study drugs

3. Use of medications or supplements that would preclude or confound study drugs

4. Past treatment of headache or dizziness with a full trial of a calcium channel blocker or selective serotonin reuptake inhibitor

5. Allergy to verapamil or sertraline

Locations

Location

Status